Stockreport

Insider Sell: President, Worldwide R&D Henry Fuchs Sells 35,341 Shares of Biomarin ... [Yahoo! Finance]

BioMarin Pharmaceutical Inc.  (BMRN) 
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.biomarin.com
PDF The transaction was executed at an average price of $85.18 per share, resulting in a total value of $3,009,831.38. Biomarin Pharmaceutical Inc, headquartered in San Ra [Read more]